All In Biotech

Free tool

FAERS Monitor: Bondlido

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 215029 or its brand name (Bondlido, Lidocaine). Reports on generic versions are filed under their own applications.

Reports

49,631

Serious

36,212

73% of reports

Hospitalization

17,853

Death reported

5,053

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective3,671
  • pain3,213
  • fatigue3,108
  • nausea3,093
  • headache2,856
  • off label use2,678
  • dyspnoea2,217
  • pneumonia2,054
  • diarrhoea2,011
  • sinusitis1,951
  • vomiting1,886
  • fall1,739
  • product dose omission issue1,738
  • dizziness1,733
  • death1,711

Reports by year received

View as table
YearReports
2004281
2005257
2006318
2007314
2008376
2009451
2010531
20111,089
20121,215
2013757
20141,133
20151,871
20163,208
20172,539
20183,295
20194,120
20205,396
20213,785
20223,521
20233,880
20243,956
20254,122
20263,212

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,004,528 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sinusitisSignal1,9518.27.912,160
pneumoniaSignal2,0542.72.62,216
product dose omission issueSignal1,7382.52.41,596
painSignal3,2132.22.12,214
fallSignal1,7392.22.11,178
headache2,8561.91.91,322
vomiting1,8861.71.6557
fatigue3,1081.71.6914
dyspnoea2,2171.71.6598
nausea3,0931.71.6837
dizziness1,7331.51.4269
diarrhoea2,0111.31.3161
off label use2,6781.31.3189
drug ineffective3,6711.21.1108
death1,7110.80.853

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.